The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia

Drug and Alcohol Review

Volumn 27, Issue 2, 2008, Pages 145-151

  Degenhardt, Louisa ^a,f   Roxburgh, Amanda ^a,f   Van Beek, Ingrid ^b   Hall, Wayne D ^c   Robinson, Maxine K F ^d   Ross, Joanne ^a   Mant, Andrea ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b South Eastern Sydney and Illawarra Area Health Service   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d Australian Government Department of Health and Ageing ^*  (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

benzodiazepines; dependence; injecting drug use; surveillance

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; TEMAZEPAM;

ARTICLE; AUSTRALIA; CROSS-SECTIONAL STUDY; DRUG THERAPY; GEL; HEALTH CARE COST; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MICROCAPSULE; ORGANIZATION AND MANAGEMENT; PRESCRIPTION; RESIDENTIAL CARE; STATISTICS; SUBSTANCE ABUSE;

ANTI-ANXIETY AGENTS; AUSTRALIA; BENZODIAZEPINES; CAPSULES; CATCHMENT AREA (HEALTH); CROSS-SECTIONAL STUDIES; DRUG THERAPY; GELS; HEALTH CARE SECTOR; HUMANS; INJECTIONS, INTRAVENOUS; PRESCRIPTIONS, DRUG; PUBLIC SECTOR; SUBSTANCE ABUSE, INTRAVENOUS; TEMAZEPAM;

EID: 38949206507     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701829413     Document Type: Article

References (26)

1. Gelkopf M, Bleich A, Hayward R, Bodner G, Adelson M. Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug Alcohol Depend 1999;55: 63-8.
2. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 1993;32:257-66.
3. Darke S. The use of benzodiazepines among injecting drug users. Drug Alcohol Rev 1994;13:63-9.
4. Strang J, Griffiths P, Abbey J, Gossop M. Survey of injected benzodiazepines among drug users in Britain. Br Med J 1994;308:1082.
5. Dupont RL. Abuse of benzodiazepines: the problems and the solutions. Am J Drug Alcohol Abuse 1998;14(Suppl 1): 1-69.
6. Klee H, Fluagie J, Hayes C, Boulton T, Morris J. AIDS related risk behaviour, polydrug use and temazepam. Br J Addict 1990;85:1125-32.
7. Ross J, Darke S, Hall W. Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procure-ment. Drug Alcohol Rev 1996;15:237-43.
8. Fry C, Smith B, Bruno R, O'Keeffe B, Miller P. Benzodiazepine and pharmaceutical opioid misuse and their relationship to crime: an examination of illicit prescription drug markets in Melbourne, Hobart and Darwin-national overview report. Fitzroy: Turning Point Alcohol and Drug Centre, 2004.
9. Ross J, Darke S. The nature of benzodiazepine dependence among heroin users in Sydney. Australia. Addiction 2000; 95:1785-93.
10. Ross J, Darke S, Hall W. Transitions between routes of benzodiazepine administration among heroin users in Sydney, Australia. Addiction 1997;92:697-795.
11. Eddey DP, Westcott MJ. 'The needle and the damage done': inter-arterial temazepam. Emerg Med 2000;12:248-52.
12. Feeney G, Gibbs H. Digit loss following misuse of temazepam. Med J Aust 2002; 176:380.
13. Fountain J, Griffiths P, Farrel M, Gossop M, Strang J. Benzodiazepine in polydrug using repertoires: the impact of the decreased availability of temazepam gel-filled capsules. Drugs Educ Prev Policy 1999;6:61-9.
14. Darke S, Ross J, Hall W. Benzodiazepine use among injecting heroin users. Med J Aust 1995;162:645-7.
15. Breen C, Degenhardt L, Bruno R, Roxburgh A, Jenkinson R. The impact of the restriction of publicly subsidised 10mg temazepam capsules upon benzodiazepine use among injecting drug users in Australia. Med J Aust 2004; 181: 300-5.
16. Breen C, Degenhardt L, Roxburgh A, et al. The impact of a change in the availability of publicly subsidised temazepam gel capsules in Australia. NDARC Technical Report no. 158. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2003.
17. Wilce H. Complications associated with the intentional misuse of temazepam gelcaps among injecting drug users. Sydney: Kirketon Road Centre, 2003.
18. Black E, Degenhardt L, Stafford J. New South Wales drug trends 2005: findings from the Illicit Drug Reporting System (IDRS). NDARC Technical Report no. 248. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2006.
19. Topp L, McKetin R. Supporting evidence-based policy-making: a case study of the IDRS. Bull Narcotics 2003; LV:23-30.
20. Topp L, McKetin R. The IDRS: a timely, effective and cost-effective way to support evidence-based policymaking. 2001. Available at: http://ndarc.med. unsw. edu.au/ndarc.nsf/website/IDRS (accessed 19 September 2005).
21. Degenhardt L, Black E, Breen C, et al. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev 2006;25:403-12.
22. Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend 1997;48:135-41.
23. Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend 2003;70:275-86.
24. Degenhardt L, Day C, Dietze P, et al. Effects of a sustained heroin shortage in three Australian States. Addiction 2005; 100:908-20.
25. Roxburgh A, Degenhardt L, Breen C. Changes in patterns of drug use among injecting drug users following a reduction in the availability of heroin in New South Wales, Australia. Drug Alcohol Rev 2004;23:287-94.
26. O'Brien S, Black E, Roxburgh A, et al. Australian drug trends 2006: findings from the Illicit Drug Reporting System (IDRS). NDARC Monograph. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2007.